The Scientist

» retraction and cell & molecular biology

Most Recent

image: Scandalous GSK Paper Retracted

Scandalous GSK Paper Retracted

By | December 10, 2013

The publication at the center of a June controversy for drugmaker GlaxoSmithKline is finally pulled from the literature.

4 Comments

image: Week in Review: December 2–6

Week in Review: December 2–6

By | December 6, 2013

Oldest hominin DNA sequence; visualizing dyslexia; testing CRISPR; cancer and autoimmunity

0 Comments

image: GMO Retraction Sparks Retribution

GMO Retraction Sparks Retribution

By | December 5, 2013

A journal faces a potential lawsuit and a boycott after retracting a study about genetically modified crops.

6 Comments

image: A Cancer Culprit in Autoimmunity

A Cancer Culprit in Autoimmunity

By | December 5, 2013

Scientists discover that cancer can drive the autoimmune disorder scleroderma.

0 Comments

image: Opinion: Of Mice and Men

Opinion: Of Mice and Men

By | December 3, 2013

Researchers scramble to put mouse cancer models on solid footing.

1 Comment

image: Contributors

Contributors

By | December 1, 2013

Meet some of the people featured in the December 2013 issue of The Scientist.

0 Comments

image: Intracellular Spirals

Intracellular Spirals

By | December 1, 2013

Membrane twists connect stacked endoplasmic reticulum sheets.

0 Comments

image: Organelle Architecture

Organelle Architecture

By | December 1, 2013

There’s beauty in a cell’s marriage of structure and function.

1 Comment

image: Proto-Organelles for Synthetic Cells

Proto-Organelles for Synthetic Cells

By | December 1, 2013

Researchers construct lipid-encapsulated compartments within synthetic cells.

2 Comments

image: One Man's Trash...

One Man's Trash...

By | December 1, 2013

Scientists who dared to waste their time looking at the midbody, a remnant of cell division, have catapulted the organelle to new prominence.

2 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech